92 related articles for article (PubMed ID: 2425385)
1. Serum alphaphetoprotein in chronic hepatitis. Scintigraphic correlations.
Gheorghe N; Boerescu I; Ciuntu L; Coman M; Boroş I
Physiologie; 1986; 23(2):131-8. PubMed ID: 2425385
[TBL] [Abstract][Full Text] [Related]
2. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
3. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
4. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
Halm U; Tannapfel A; Mössner J; Berr F
Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
[TBL] [Abstract][Full Text] [Related]
5. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
[TBL] [Abstract][Full Text] [Related]
6. [Correlations between alpha fetoprotein levels and hepatic cytolysis in acute viral hepatitis].
Corridori S; Pietrogrande M; Scevola D; Vender A; Cerrato P; Lago A
Riv Emoter Immunoematol; 1980; 27(3-4):135-41. PubMed ID: 6176004
[No Abstract] [Full Text] [Related]
7. The interleukin-17 pathway is involved in human alcoholic liver disease.
Lemmers A; Moreno C; Gustot T; Maréchal R; Degré D; Demetter P; de Nadai P; Geerts A; Quertinmont E; Vercruysse V; Le Moine O; Devière J
Hepatology; 2009 Feb; 49(2):646-57. PubMed ID: 19177575
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
11. Serum aminotransferase levels and histological disease in chronic hepatitis C.
Michielsen PP; Hauben EI; Ramon AM; Van Marck EA; Pelckmans PA
Acta Gastroenterol Belg; 1997; 60(1):11-4. PubMed ID: 9144972
[TBL] [Abstract][Full Text] [Related]
12. Cryptogenic liver disease in a young woman.
Miller DJ
J Clin Gastroenterol; 1979 Jun; 1(2):157-64. PubMed ID: 95607
[No Abstract] [Full Text] [Related]
13. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenetic importance of proinflammatory cytokines in the formation and progression of fibrosis in alcoholic hepatitis].
Kliaritskaia IL; Stilidi EI
Eksp Klin Gastroenterol; 2013; (4):13-20. PubMed ID: 24294778
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the phytohepatoprotective agent maxar on the hepatic morphofunctional status in patients with chronic hepatitis].
Beloborodova EI; Gaĭsaev RO; Saratikov AS
Klin Med (Mosk); 2004; 82(12):39-42. PubMed ID: 15732719
[TBL] [Abstract][Full Text] [Related]
17. Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.
Mendenhall CL; Roos F; Moritz TE; Roselle GA; Chedid A; Grossman CJ; Rouster SD; Bennett GL; Lake JR
Alcohol Clin Exp Res; 1996 Dec; 20(9):1625-30. PubMed ID: 8986214
[TBL] [Abstract][Full Text] [Related]
18. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
19. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
Spech HJ; Liehr H; Mitschke H
Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic gammagraphy in alcoholism. Its relation to digestive radiology].
Navarro Izquierdo AL; Galbe Sada R; Duque Gallo JJ; Ros Mendoza L; Solsona F
Rev Esp Enferm Apar Dig; 1984 Dec; 66(6):523-9. PubMed ID: 6522789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
